Acquired mutations in genes encoding for spliceosome proteins and other regulatory splicing factors are reported in all myeloid malignancies, particularly MPN and MDS, and mainly affect SRSF2, U2AF1, ZRSR2, and SF3B1 genes. Here, U2AF1 is linked to myeloproliferative disorder.